JBS N.V. Discusses Q4 2025 Performance and Outlook
Discover key takeaways
JBS N.V. Discusses Q4 2025 Performance and Outlook Read More »
$QDT Quadient Publishes Q4 2026 Earnings Call Presentation Key Takeaways Quadient S.A. has officially published its Q4 2026 Earnings Call Presentation, detailing financial performance for the period, per the company’s investor relations update. The presentation covers the fourth quarter of fiscal year 2026, providing insights into the company’s operational results and strategic outlook, as stated
Quadient Publishes Q4 2026 Earnings Call Presentation Read More »
$COLL Q4 2025 Earnings Call Concludes Amid Market Anticipation Key Takeaways Collegium Pharmaceutical, Inc. (COLL) held its **Q4 2025** earnings call presentation, as scheduled, to discuss its financial performance and operational updates. (Source: Collegium Pharmaceutical) The presentation covered the company’s performance for the quarter ending **December 31, 2025**, typically including revenue, net income, and strategic
Collegium Pharmaceutical (COLL) Concludes Q4 2025 Earnings Call Read More »
$MDXG Reports Strong Q4 2025 Performance, Exceeding Revenue Forecasts Key Takeaways MiMedx Group, Inc. (MDXG) reported Q4 2025 revenue of $110.3 million, marking a significant 15.2% increase year-over-year, surpassing analyst consensus, per Q4 2025 Earnings Call Transcript. Net income for the quarter reached $12.5 million, translating to $0.09 per diluted share, demonstrating improved profitability and
MiMedx Group Reveals Robust Q4 2025 Results Amidst Strategic Growth Initiatives Read More »